NeoBiocon to sell anti-diabetic drug in UAE
Vildagliptin is available as monotherapy and in combination with metformin. Both the drugs commands over 30 percent of the DPP-IV market in the UAE.
Dec 10, 2015, 20:47 PM IST
NeoBiocon partners Novartis to launch diabetes drugs in UAE
NeoBiocon, a collaboration between Biocon Ltd and BR Shetty led UAE-based Neopharma, has partnered with Novartis Middle East FZE to market diabetes drugs Jalra and Jalra-M in the UAE.
Dec 09, 2015, 22:55 PM IST
Antim Baazi: NeoBiocon Partners with Novartis
NeoBiocon Partners with Novartis which shows good momentum in Biocon intra-day trading.
Dec 09, 2015, 19:38 PM IST
